Indivior Pharmaceuticals (INDV) Profit After Tax (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Profit After Tax of $89.0 million for Q1 2026, up 89.36% year-over-year from $47.0 million in Q1 2025, and down 12.75% quarter-over-quarter from $102.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Profit After Tax (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Profit After Tax history runs 3 years deep, the most recent figure standing at $89.0 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 89.36% year-over-year to $89.0 million; the TTM figure through Mar 2026 stood at $251.0 million (up 3685.71% YoY), while the FY2025 annual figure was $210.0 million, up 2900.0% from the prior year.
- Profit After Tax for Q1 2026 stood at $89.0 million, down from $102.0 million in the prior quarter.
- The five-year high for Profit After Tax was $102.0 million in Q4 2025, with the low at -$97.0 million in Q2 2024.
- The 3-year median for Profit After Tax is $42.0 million (2025), against an average of $33.9 million.
- Peak annual rise in Profit After Tax reached 385.71% in 2025, while the deepest fall reached 22.95% in 2025.
- Indivior Pharmaceuticals' Profit After Tax stood at $21.0 million in 2024, then surged by 385.71% to $102.0 million in 2025, then decreased by 12.75% to $89.0 million in 2026.
- Business Quant data shows INDV's Profit After Tax at $89.0 million in Q1 2026, $102.0 million in Q4 2025, and $42.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.57 Bn | 4.35 Bn | 294.00 Mn | 122.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 122.00 Mn |
| Mar 31, 2026 | 89.00 Mn |
| Dec 31, 2025 | 102.00 Mn |
| Sep 30, 2025 | 42.00 Mn |
| Jun 30, 2025 | 18.00 Mn |
| Mar 31, 2025 | 47.00 Mn |
| Dec 31, 2024 | 21.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | -97.00 Mn |
| Mar 31, 2024 | 61.00 Mn |